Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000867

Chief Commercial Officer sold 74 shares at $33.89 ($2,508)

  • Chief Commercial Officer acquired 75,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Oliver Tracie Chief Commercial Officer 2024-01-04 Grant or award 10b5-1 +75,000 136,575 D: show line 1 in the form
Oliver Tracie Chief Commercial Officer 2024-01-05 Sale 10b5-1 −74 $33.89 $2,508 136,501 D: show line 2 in the form
Open-market sales · 74 sh · avg $33.89 · $2,508
Loading xslF345X05/wk-form4_1704752243.xml…